Keytruda shows a 35% reduced risk of disease progression or death against a type of aggressive breast cancer. Read more here.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Taysha Gene Therapies disclosed details of a planned trial for its treatment for Rett syndrome and filed for a secondary share offering. The biotechnology company said its Part B trial for TSHA-102, ...

Shares of Taysha Gene Therapies climbed after the company announced details of a planned trial for its treatment for Rett syndrome and filed for a secondary share offering. The stock rose 13% to $2.76 ...

U.S. senator wants to know how the FDA will enforce drug ad regulations after letting go numerous workers from the office ...

Spero Therapeutics (SPRO) stock jumps as GSK (GSK) partnered oral UTI treatment, tebipenem HBr, succeeds in a pivotal Phase 3 ...

Explore the best investing ideas for 2025 at Investorideas.com. Get stock news, podcasts, videos, and insights on AI, crypto, ...